A citation-based method for searching scientific literature

Anzelle Delport, Brian H Harvey, Anél Petzer, Jacobus P Petzer. Metab Brain Dis 2017
Times Cited: 21







List of co-cited articles
100 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


From Mitochondrial Function to Neuroprotection-an Emerging Role for Methylene Blue.
Donovan Tucker, Yujiao Lu, Quanguang Zhang. Mol Neurobiol 2018
56
38

Methylene Blue Analogues with Marginal Monoamine Oxidase Inhibition Retain Antidepressant-like Activity.
Anzelle Delport, Brian H Harvey, Anél Petzer, Jacobus P Petzer. ACS Chem Neurosci 2018
9
77

Methylene blue treatment for residual symptoms of bipolar disorder: randomised crossover study.
Martin Alda, Margaret McKinnon, Ryan Blagdon, Julie Garnham, Susan MacLellan, Claire O'Donovan, Tomas Hajek, Cynthia Nair, Serdar Dursun, Glenda MacQueen. Br J Psychiatry 2017
28
28

A controlled trial of methylene blue in severe depressive illness.
G J Naylor, A H Smith, P Connelly. Biol Psychiatry 1987
61
19


"Lest we forget you--methylene blue...".
R Heiner Schirmer, Heike Adler, Marcus Pickhardt, Eckhard Mandelkow. Neurobiol Aging 2011
200
19

Methylene blue delays cellular senescence and enhances key mitochondrial biochemical pathways.
Hani Atamna, Andy Nguyen, Carla Schultz, Kathleen Boyle, Justin Newberry, Hiroyuki Kato, Bruce N Ames. FASEB J 2008
193
19

Cellular and molecular actions of Methylene Blue in the nervous system.
Murat Oz, Dietrich E Lorke, Mohammed Hasan, George A Petroianu. Med Res Rev 2011
162
14

The monoamine oxidase inhibition properties of selected structural analogues of methylene blue.
Anzelle Delport, Brian H Harvey, Anél Petzer, Jacobus P Petzer. Toxicol Appl Pharmacol 2017
11
27

N-Acetyl cysteine reverses social isolation rearing induced changes in cortico-striatal monoamines in rats.
Marisa Möller, Jan L Du Preez, Francois P Viljoen, Michael Berk, Brian H Harvey. Metab Brain Dis 2013
28
14

Social isolation rearing induces mitochondrial, immunological, neurochemical and behavioural deficits in rats, and is reversed by clozapine or N-acetyl cysteine.
Marisa Möller, Jan L Du Preez, Francois P Viljoen, Michael Berk, Robin Emsley, Brian H Harvey. Brain Behav Immun 2013
112
14

Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: Methylene blue connects the dots.
Shao-Hua Yang, Wenjun Li, Nathalie Sumien, Michael Forster, James W Simpkins, Ran Liu. Prog Neurobiol 2017
35
14

Methylene blue. A possible treatment for manic depressive psychosis.
S L Narsapur, G J Naylor. J Affect Disord 1983
50
14




Paroxetine is a novel nitric oxide synthase inhibitor.
M S Finkel, F Laghrissi-Thode, B G Pollock, J Rong. Psychopharmacol Bull 1996
141
14


Pharmacokinetics and organ distribution of intravenous and oral methylene blue.
C Peter, D Hongwan, A Küpfer, B H Lauterburg. Eur J Clin Pharmacol 2000
224
14

Alternative mitochondrial electron transfer as a novel strategy for neuroprotection.
Yi Wen, Wenjun Li, Ethan C Poteet, Luokun Xie, Cong Tan, Liang-Jun Yan, Xiaohua Ju, Ran Liu, Hai Qian, Marian A Marvin,[...]. J Biol Chem 2011
178
14


Efficacy and safety of methylene blue in the treatment of malaria: a systematic review.
G Lu, M Nagbanshi, N Goldau, M Mendes Jorge, P Meissner, A Jahn, F P Mockenhaupt, O Müller. BMC Med 2018
37
14

Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature.
J Pelgrims, F De Vos, J Van den Brande, D Schrijvers, A Prové, J B Vermorken. Br J Cancer 2000
146
14

Effects of methylene blue in reducing cholestatic oxidative stress and hepatic damage after bile-duct ligation in rats.
Burhan Aksu, Hasan Umit, Mehmet Kanter, Ahmet Guzel, Cevat Aktas, Sabiha Civelek, Hafize Uzun. Acta Histochem 2010
27
9





Methylene blue and Alzheimer's disease.
Murat Oz, Dietrich E Lorke, George A Petroianu. Biochem Pharmacol 2009
142
9

Lithium salts in AIDS and AIDS-related dementia.
Brian H Harvey, Catharina L Meyer, Vincent S Gallichio, Husseini K Manji. Psychopharmacol Bull 2002
14
14


Neuroprogression in schizophrenia: Pathways underpinning clinical staging and therapeutic corollaries.
Justin Davis, Steven Moylan, Brian H Harvey, Michael Maes, Michael Berk. Aust N Z J Psychiatry 2014
93
9

Efavirenz: What is known about the cellular mechanisms responsible for its adverse effects.
Nadezda Apostolova, Ana Blas-Garcia, Maria J Galindo, Juan V Esplugues. Eur J Pharmacol 2017
23
9

Dysregulated relationship of inflammation and oxidative stress in major depression.
B J Rawdin, S H Mellon, F S Dhabhar, E S Epel, E Puterman, Y Su, H M Burke, V I Reus, R Rosser, S P Hamilton,[...]. Brain Behav Immun 2013
143
9

Methylene blue attenuates traumatic brain injury-associated neuroinflammation and acute depressive-like behavior in mice.
Ashley M Fenn, John P Skendelas, Daniel N Moussa, Megan M Muccigrosso, Phillip G Popovich, Jonathan Lifshitz, Daniel S Eiferman, Jonathan P Godbout. J Neurotrauma 2015
62
9

Methylene blue excretion in depression.
J P Moody, S M Allan, A H Smith, G J Naylor. Biol Psychiatry 1989
4
50

Neuroprotective and Functional Improvement Effects of Methylene Blue in Global Cerebral Ischemia.
Qing Lu, Donovan Tucker, Yan Dong, Ningjun Zhao, Quanguang Zhang. Mol Neurobiol 2016
37
9


Oxidative stress markers in bipolar disorder: a meta-analysis.
Ana C Andreazza, Marcia Kauer-Sant'anna, Benicio N Frey, David J Bond, Flavio Kapczinski, L Trevor Young, Lakshmi N Yatham. J Affect Disord 2008
335
9

The promise of N-acetylcysteine in neuropsychiatry.
Michael Berk, Gin S Malhi, Laura J Gray, Olivia M Dean. Trends Pharmacol Sci 2013
256
9

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders.
Gin S Malhi, Darryl Bassett, Philip Boyce, Richard Bryant, Paul B Fitzgerald, Kristina Fritz, Malcolm Hopwood, Bill Lyndon, Roger Mulder, Greg Murray,[...]. Aust N Z J Psychiatry 2015
388
9

Design and rationale of a 16-week adjunctive randomized placebo-controlled trial of mitochondrial agents for the treatment of bipolar depression.
Olivia M Dean, Alyna Turner, Gin S Malhi, Chee Ng, Sue M Cotton, Seetal Dodd, Jerome Sarris, Yuval Samuni, Michelle Tanious, Nathan Dowling,[...]. Braz J Psychiatry 2015
28
9

Oxidative stress in psychiatric disorders: evidence base and therapeutic implications.
Felicity Ng, Michael Berk, Olivia Dean, Ashley I Bush. Int J Neuropsychopharmacol 2008
633
9

α-Mangostin: anti-inflammatory activity and metabolism by human cells.
Fabiola Gutierrez-Orozco, Chureeporn Chitchumroonchokchai, Gregory B Lesinski, Sunit Suksamrarn, Mark L Failla. J Agric Food Chem 2013
49
9

Histaminergic and serotonergic receptor blocking substances from the medicinal plant Garcinia mangostana.
N Chairungsrilerd, K Furukawa, T Ohta, S Nozoe, Y Ohizumi. Planta Med 1996
39
9

Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors.
M Berk, F Kapczinski, A C Andreazza, O M Dean, F Giorlando, M Maes, M Yücel, C S Gama, S Dodd, B Dean,[...]. Neurosci Biobehav Rev 2011
754
9

N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial.
Michael Berk, David L Copolov, Olivia Dean, Kristy Lu, Sue Jeavons, Ian Schapkaitz, Murray Anderson-Hunt, Ashley I Bush. Biol Psychiatry 2008
323
9

Beyond the therapeutic shackles of the monoamines: New mechanisms in bipolar disorder biology.
João Data-Franco, Ajeet Singh, Dina Popovic, Melanie Ashton, Michael Berk, Eduard Vieta, M L Figueira, Olivia M Dean. Prog Neuropsychopharmacol Biol Psychiatry 2017
23
9

Regulation of adult neurogenesis by antidepressant treatment.
R S Duman, S Nakagawa, J Malberg. Neuropsychopharmacology 2001
337
9

Azure B, a metabolite of methylene blue, is a high-potency, reversible inhibitor of monoamine oxidase.
Anél Petzer, Brian H Harvey, Gregers Wegener, Jacobus P Petzer. Toxicol Appl Pharmacol 2012
60
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.